Barinthus Biotherapeutics
  • Home
  • About Us
    • Overview
    • Our Team
    • A Name with Purpose
  • Technology
    • Overview
    • Viral Vector Platforms
    • Synthetic Platforms
  • Pipeline
    • Overview
    • Infectious Diseases
    • Autoimmunity
    • Cancer
  • Partnerships
    • Overview
    • Infectious Diseases
    • Autoimmunity
    • Cancer
  • Investors
    • Overview
    • News & Filings
    • Events & Presentations
    • Stock Information
    • Corporate Governance
    • Investor FAQs
    • Contact IR
  • Careers
    • Overview
    • Recruitment Companies
  • Contact
    • Overview
    • Patient Enquiries
Select Page

SITEMAP

Looking for something in particular?

Authors

    Pages

    • About Us
      • A Name with Purpose
      • Our Team
    • Careers
      • Recruitment Companies
    • Contact
      • Patient Enquiries
    • Data Protection Policy
    • Home
    • Partnerships
      • Autoimmunity
      • Cancer
      • Infectious Diseases
    • Pipeline
      • Autoimmunity
      • Cancer
      • Infectious Diseases
    • Privacy Notice
    • Privacy Policy
    • Technology
      • Synthetic Platforms
      • Viral Vector Platforms

    Barinthus Biotherapeutics plc

    Unit 6-10
    Zeus Building
    Rutherford Avenue
    Harwell OX11 0DF
    United Kingdom

    T: +44 (0)1865 818808

    Home
    About
    Sitemap
    Privacy Policy
    Privacy Notice
    Careers
    Contact

    Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company focused on the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer.

    © Barinthus Biotherapeutics 2023 All rights reserved.

    • Follow
    • Follow